These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8386497)

  • 1. In vitro and in vivo activity of alkylating bombesin receptor antagonists on small cell lung carcinoma.
    Ciomei M; Pastori W; Pastori A; de Castiglione R; Gozzini L; Corradi F
    Anticancer Res; 1993; 13(1):75-9. PubMed ID: 8386497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumoral activity of bombesin analogues on small cell lung cancer xenografts: relationship with bombesin receptor expression.
    Thomas F; Arvelo F; Antoine E; Jacrot M; Poupon MF
    Cancer Res; 1992 Sep; 52(18):4872-7. PubMed ID: 1325285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bombesin receptor antagonists. 3. Irreversible alkylating analogues: melphalan derivatives.
    de Castiglione R; Gozzini L; Galantino M; Corradi F; Arlandini E; Molinari I; Ciomei M
    Farmaco; 1991 Jun; 46(6):743-57. PubMed ID: 1663360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo.
    Mahmoud S; Staley J; Taylor J; Bogden A; Moreau JP; Coy D; Avis I; Cuttitta F; Mulshine JL; Moody TW
    Cancer Res; 1991 Apr; 51(7):1798-802. PubMed ID: 1848479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of bombesin antagonists on the growth of small cell lung cancer cells in vitro.
    Layton JE; Scanlon DB; Soveny C; Morstyn G
    Cancer Res; 1988 Sep; 48(17):4783-9. PubMed ID: 2457430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo.
    Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K
    Cancer Res; 1994 Nov; 54(22):5895-901. PubMed ID: 7954420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of neuropeptide analogues on calcium flux and proliferation in lung cancer cell lines.
    Bunn PA; Chan D; Stewart J; Gera L; Tolley R; Jewett P; Tagawa M; Alford C; Mochzuki T; Yanaihara N
    Cancer Res; 1994 Jul; 54(13):3602-10. PubMed ID: 7516822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bombesin receptor antagonists. 4. Chloromethylketone and chloroethylnitrosourea derivatives.
    Lucietto P; de Castiglione R; Gozzini L
    Farmaco; 1991 Oct; 46(10):1111-20. PubMed ID: 1667726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of bombesin receptors using a novel, potent, radiolabeled antagonist that distinguishes bombesin receptor subtypes.
    Mantey S; Frucht H; Coy DH; Jensen RT
    Mol Pharmacol; 1993 May; 43(5):762-74. PubMed ID: 7684815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of bombesin on human small cell lung cancer cells: evidence for a subset of bombesin non-responsive cell lines.
    Kado-Fong H; Malfroy B
    J Cell Biochem; 1989 Aug; 40(4):431-7. PubMed ID: 2550492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting gastrin-releasing peptide receptors on small cell lung cancer cells with a bispecific molecule that activates polyclonal T lymphocytes.
    Zhou J; Chen J; Zhong R; Mokotoff M; Shultz LD; Ball ED
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2224-31. PubMed ID: 16609038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 expression influences the growth of human large and small cell lung carcinoma lines in athymic mice: impact of an organoselenium compound on growth regulation.
    El-Bayoumy K; Rose DP; Papanikolaou N; Leszczynska J; Swamy MV; Rao CV
    Int J Oncol; 2002 Mar; 20(3):557-61. PubMed ID: 11836568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic stability and tumor inhibition of bombesin/GRP receptor antagonists.
    Davis TP; Crowell S; Taylor J; Clark DL; Coy D; Staley J; Moody TW
    Peptides; 1992; 13(2):401-7. PubMed ID: 1329046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
    Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K; O'Byrne K; Cai RZ
    Br J Cancer; 1994 Nov; 70(5):886-92. PubMed ID: 7947094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted cytotoxic analogue of bombesin/gastrin-releasing peptide inhibits the growth of H-69 human small-cell lung carcinoma in nude mice.
    Kiaris H; Schally AV; Nagy A; Sun B; Armatis P; Szepeshazi K
    Br J Cancer; 1999 Nov; 81(6):966-71. PubMed ID: 10576652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective stimulation of small cell lung cancer clonal growth by bombesin and gastrin-releasing peptide.
    Carney DN; Cuttitta F; Moody TW; Minna JD
    Cancer Res; 1987 Feb; 47(3):821-5. PubMed ID: 3026617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bombesin/gastrin-releasing peptide receptor: a potential target for antibody-mediated therapy of small cell lung cancer.
    Zhou J; Chen J; Mokotoff M; Zhong R; Shultz LD; Ball ED
    Clin Cancer Res; 2003 Oct; 9(13):4953-60. PubMed ID: 14581370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology and cell biology of the bombesin receptor subtype 4 (BB4-R).
    Katsuno T; Pradhan TK; Ryan RR; Mantey SA; Hou W; Donohue PJ; Akeson MA; Spindel ER; Battey JF; Coy DH; Jensen RT
    Biochemistry; 1999 Jun; 38(22):7307-20. PubMed ID: 10353842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bombesin receptor antagonists [corrected]. 1. Analogues with deleted, inverted or substituted amino acid residues.
    De Castiglione R; Gozzini L; Mena R; Brugnolotti M; Ciomei M; Molinari I; Comoglio PM; Gaudino G
    Farmaco; 1990 Dec; 45(12):1251-63. PubMed ID: 1965286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New short-chain analogs of a substance-P antagonist inhibit proliferation of human small-cell lung-cancer cells in vitro and in vivo.
    Orosz A; Schrett J; Nagy J; Bartha L; Schön I; Nyéki O
    Int J Cancer; 1995 Jan; 60(1):82-7. PubMed ID: 7529212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.